Clinical Trial

A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-31
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-17
Trial Details
NCT Number NCT07502417
Lead Sponsor AbbVie
Conditions Healthy Volunteer
Enrollment 15 participants
Start Date 2026-03-27
Primary Completion 2026-07-02 (estimated)
Study Completion 2026-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-30